# Progress Note 07 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Rachel Carson (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML041-SYN
- Date: 2026-10-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Margaret Vance-Okonkwo, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning) on the same day

## Chief complaint

Adult preventive visit; no new complaints. **S**

## History of present illness

Ms. Carson returns for her yearly preventive visit, in her fifth ribociclib cycle and four months into letrozole. The cold in July settled in about a week without antibiotics. She has mild morning stiffness in her knees, eased by walking, and occasional hot flashes at night. She finished the draft of her book last month and is now revising it. She completed the health risk assessment before the visit. **S**

| Element | Detail |
|---|---|
| Visit | Adult preventive visit, age 53 |
| Active conditions | Left breast cancer after lumpectomy and radiation, on letrozole, ribociclib, and zoledronic acid; low bone mass; knee osteoarthritis |
| Medicines | Letrozole 2.5 mg daily; ribociclib 400 mg on days 1 to 21 of each cycle; zoledronic acid every six months; vitamin D3 1000 units daily; acetaminophen as needed |
| Recent events | Viral rhinosinusitis in July, resolved |
| Functional status | Independent; walking 30 minutes most days |

## Health risk assessment

Completed by the patient before the visit and reviewed during the visit. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good, and better than she expected during treatment |
| Psychosocial | A close friend and her editor are her main supports; no financial strain; feels safe at home; shares her diagnosis with a few people of her choosing |
| Behavioral | Never smoker; a small glass of sherry a few times a month; walks most days; eats fish, vegetables, and dairy |
| Activities of daily living | Independent in all |
| Instrumental activities of daily living | Manages her own medicines, money, correspondence, and household |
| Home safety | Smoke detectors working; wears a seat belt; no falls |
| Hearing and vision | Reading glasses; eye examination last year; hearing normal |
| Sleep | About seven hours a night, sometimes woken by a hot flash |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; no fever or night sweats beyond hot flashes |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | Sinus symptoms resolved |
| Cardiovascular | Negative | No chest pain, palpitations, fainting, or leg swelling |
| Respiratory | Negative | No cough or breathlessness |
| Breast | Negative | No new lump in either breast; left breast firmer since radiation |
| Gastrointestinal | Negative | No indigestion, black stools, or diarrhea |
| Genitourinary | Positive | Mild vaginal dryness; no bleeding or urinary symptoms |
| Musculoskeletal | Positive | Morning knee stiffness for about 15 minutes; no bone pain |
| Integumentary | Negative | No rash; radiation skin healed |
| Neurological | Negative | No headaches or numbness |
| Psychiatric | Negative | Mood good; PHQ-2 score 0 |

12 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for knee pain, no more than 3000 mg a day **S**
- Letrozole 2.5 mg oral tablet, one tablet by mouth once daily, planned for at least five years **S**
- Ribociclib 200 mg oral tablet, two tablets (400 mg) by mouth once daily on days 1 to 21 of each 28-day cycle, with letrozole, planned for three years **S**
- Zoledronic acid 4 mg in 100 mL intravenous infusion over 15 minutes every six months for three years **S**
- Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 116/74 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 59.8 kg; BMI 22.5 kg/m². All vital signs are synthetic.

PHQ-2: 0; AUDIT-C: 1. All results are synthetic.

## Change since baseline

- PHQ-2: 1 at baseline, 0 at this visit **S**

## Immunizations given today

- Influenza vaccine, 2026-2027 season **S**
- Pneumococcal conjugate vaccine PCV20 **S**
- Recombinant zoster vaccine, dose 1 of 2 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well-appearing; BMI 22.5 |
| Eyes | Pupils equal and reactive |
| Neck | No thyroid enlargement or nodes |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Respiratory | Clear |
| Breasts | Left lumpectomy scar healed; mild firmness and tanning of the treated breast from radiation; no masses in either breast |
| Lymph nodes | No axillary or supraclavicular nodes |
| Extremities | Arm circumference 25.5 cm on each side 10 cm above the elbow; full shoulder movement; knees with mild crepitus and no effusion |
| Abdomen | Soft; no epigastric tenderness; liver not enlarged |
| Skin | No suspicious lesions |
| Psychiatric | Bright, precise, and engaged |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Adult preventive visit completed**. Health risk assessment reviewed and a written prevention plan given. Depression screen negative; AUDIT-C 1. **S**
   - Next preventive visit in one year.
2. **Left breast cancer on letrozole and ribociclib** (C50.412). No signs of recurrence. Mild vaginal dryness and night hot flashes from letrozole, which she finds tolerable. **S**
   - A non-hormonal vaginal moisturizer; no vaginal estrogen for now.
   - Continue letrozole, ribociclib, and the oncology monitoring schedule.
3. **Cardiovascular risk**. LDL cholesterol 124 mg/dL, total 208, HDL 62 four months ago; blood pressure 116/74; non-smoker; no diabetes. Estimated 10-year cardiovascular risk below 5 percent. **S**
   - No statin; diet and activity.
   - Lipids rechecked yearly on letrozole.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, 2026-2027 | Completed today | Inactivated vaccine given today |
| Pneumococcal vaccine | Completed today | PCV20 given today; recommended from age 50; no further doses needed |
| Recombinant zoster vaccine | Completed today | Dose 1 today; dose 2 in two to six months; not a live vaccine, so suitable during treatment |
| COVID-19 vaccine, 2026-2027 | Due | Recommended; she will get it at her pharmacy in two weeks |
| Hepatitis B vaccine | Due | Recommended for adults 19 to 59; series to start at the next visit if the screening test shows no immunity |
| Tetanus booster | Up to date | Tdap five years ago |
| Breast cancer screening | Not indicated | Replaced by surveillance: bilateral diagnostic mammogram six to twelve months after radiation, then yearly |
| Cervical cancer screening | Up to date | Cytology with HPV co-testing two years ago, normal; next in three years |
| Colorectal cancer screening | Up to date | Colonoscopy three years ago, normal; next at ten years |
| Osteoporosis screening | Up to date | DXA four months ago: low bone mass; on zoledronic acid; repeat in two years |
| Hepatitis B, hepatitis C, and HIV screening | Ordered | One-time screening; no prior result on record; drawn today, results pending |
| Cholesterol screening and statin decision | Completed today | Lipid panel four months ago reviewed; 10-year risk below 5 percent; no statin |
| Diabetes screening | Not indicated | BMI 22.5 without other risk factors |
| Lung cancer screening | Not indicated | Never smoker |
| Blood pressure screening | Completed today | 116/74 mmHg |
| Depression screening | Completed today | PHQ-2 score 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C 1, negative |
| Physical activity and diet counseling | Completed today | 150 minutes of walking a week, strength exercise twice a week for bone and knees, calcium from food, and alcohol at or below one drink a day |

## Advance care planning

Voluntary advance care planning discussion of about 20 minutes, with her consent. She has named a health care agent, a close friend, and completed a written health care directive today, now scanned into the chart. Her first instruction is that she is always to be told the truth about her condition, directly and in plain words, and that her clinicians must never withhold a diagnosis or a result from her or tell it to others first. Her treatment is curative in intent. If the cancer returned, she would want treatment that let her keep working and living independently; she would not want resuscitation or prolonged life support if recovery to independent life were not expected. **S**

## Guideline basis

- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Hepatitis B, hepatitis C, and HIV results by portal message. Second zoster dose in two to six months. Survivorship visit in three months; next zoledronic acid infusion in December; mammogram six to twelve months after radiation. **S**

